Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Sensitizers and ER Stress in PCOS
NCT02302326Completed
- Start
- Jan 2013
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin and myo-inositol in polycystic ovary syndrome (PCOS) (3 arms). Primary endpoints: Markers of endoplasmic reticulum stress at 3 months, Markers of the insulin pathway at 3 months and 2 more. Started Jan 2013; status: completed.
02
Drugs
metforminmyo-inositol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02302326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302326.